Skip to content

Regeneron’s COVID-19 treatment gets emergency approval from FDA

Regeneron’s COVID-19 treatment gets emergency approval from FDA

November 21, 2020 | 9:16pm

The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

XL subscribe to our newsletter banner

Get the latest news and advice on COVID-19, direct from the experts in your inbox. Join hundreds of thousands who trust experts by subscribing to our newsletter.

Send your news and stories to us news@climaxradio.co.uk or newstories@climaxnewsroom.com and WhatsApp: +447747873668.

Before you go...

Democratic norms are being stress-tested all over the world, and the past few years have thrown up all kinds of questions we didn't know needed clarifying – how long is too long for a parliamentary prorogation? How far should politicians be allowed to intervene in court cases? To monitor these issues as closely as we have in the past we need your support, so please consider donating to The Climax News Room.

Leave a Reply

Privacy Policy Designed using Unos Premium. Powered by WordPress.

Live Updates COVID-19 CASES